Market Cap 5.91B
Revenue (ttm) 5.29B
Net Income (ttm) 191.54M
EPS (ttm) N/A
PE Ratio 23.46
Forward PE 16.41
Profit Margin 3.62%
Debt to Equity Ratio 0.28
Volume 1,234,900
Avg Vol 875,218
Day's Range N/A - N/A
Shares Out 158.27M
Stochastic %K 95%
Beta 0.00
Analysts Strong Sell
Price Target $49.67

Company Profile

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 801 447 9829
Website: pacs.com
Address:
90 S. 400 W, Suite 700, Salt Lake City, United States
ReigningTrades
ReigningTrades Jun. 25 at 3:31 AM
$PACS important few weeks coming up to see if we get some upside follow through. Would not mind an initial rejection in the 41-42 range but would like to see buyers absorbing and sellers defense weakening. Should be a picture-perfect cup & handle breakout by the time the leaves start falling!
0 · Reply
Doozio
Doozio Jun. 24 at 3:25 PM
$PACS $WEN ? ONTO 🐒🍌🧠⏰♾️
0 · Reply
DrabCrab5
DrabCrab5 Jun. 24 at 2:05 PM
$PACS Two solid updates: - JPM updated their model on 6/15 and increased their price target to $47 ($44 previously) - Ohio approved $875M in retroactive quality incentive payments for skilled nursing homes following a determination that they underpaid previous quality incentive payments. As of Q1, PACS operates nearly 8% of the states total SNF beds which means they should receive a nice make whole payment.
0 · Reply
Smokesdrugs
Smokesdrugs Jun. 22 at 7:52 PM
$PACS just needs to move like this more often and it’ll be in the $50+ range where it should be in no time.
0 · Reply
Doozio
Doozio Jun. 19 at 3:04 PM
$PACS chop chop huckleberries as rotation out of semis n AI stonks (which start to consolidate) find da proper bases on the DLO ONTO 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Jun. 19 at 2:48 PM
$PACS out of the tightness da 🧠 shall spread like its staying at da $ABNB ONTO 🐒🍌🧠⏰♾️
1 · Reply
DrabCrab5
DrabCrab5 Jun. 18 at 2:57 PM
$PACS another wrinkle to this name. Mark Hancock, one of the company’s co-founders, now has a 10b5-1 plan established to sell shares. This should not come as a huge surprise given his re-retirement after filling in as stop gap CFO, as well as his massive position (~54.5m shares owned). A reduction in his ownership and increased trading liquidity should be a good thing long term, but hard to say what kind of overhang (if any) this will be. I obviously have no idea what his planning situation looks like, how many shares he wants to hold on to, etc. but without a large secondary offering, it will take him multiple years to exit his full position given the average trading volume for PACS.
1 · Reply
DrabCrab5
DrabCrab5 Jun. 18 at 2:47 PM
$PACS with only 4 SNF acquisitions completed year to date, PACS is now lagging its target of ~20 per year. Given what they have communicated about the health of their M&A pipeline, I do wonder if they are working on a chunky deal. The balance sheet is clean (net leverage is below 0.5x), they have nearly $800M in available liquidity, and will continue to generate cash as we progress through the year. One would also imagine the government investigation will come to a close at some point. The government inquiry was technically opened back in November of 2024, and PACS gave the government the findings from its own internal investigation back in November of 2025.
1 · Reply
Smokesdrugs
Smokesdrugs Jun. 17 at 7:35 PM
$PACS these stocks are dead money right now. Why invest in this when AI/tech/tech adjacent are going parabolic? Anyone who owns this is simply early, huge portion of the population are going to be in their 60s and older in the next 4 years. The government investigation overhang and the sentiment that this industry is rife with fraud certainly doesn’t help either.
1 · Reply
Smokesdrugs
Smokesdrugs Jun. 15 at 3:47 PM
0 · Reply
Latest News on PACS
PACS Group Transcript: AGM 2026

Jun 10, 2026, 1:00 PM EDT - 14 days ago

PACS Group Transcript: AGM 2026


Pacs Group price target raised to $52 from $50 at Truist

2026-05-18T12:18:22.000Z - 5 weeks ago

Pacs Group price target raised to $52 from $50 at Truist


Pacs Group price target raised to $48 from $42 at Oppenheimer

2026-05-13T11:58:22.000Z - 6 weeks ago

Pacs Group price target raised to $48 from $42 at Oppenheimer


Pacs Group rises 24.1%

2026-05-12T19:03:01.000Z - 6 weeks ago

Pacs Group rises 24.1%


Pacs Group rises 20.5%

2026-05-12T17:57:17.000Z - 6 weeks ago

Pacs Group rises 20.5%


PACS Group Earnings Call Transcript: Q1 2026

May 12, 2026, 11:30 AM EDT - 6 weeks ago

PACS Group Earnings Call Transcript: Q1 2026


PACS Group Quarterly report: Q1 2026

May 12, 2026, 11:30 AM EDT - 6 weeks ago

PACS Group Quarterly report: Q1 2026


PACS Group Earnings release: Q1 2026

May 12, 2026, 11:30 AM EDT - 6 weeks ago

PACS Group Earnings release: Q1 2026


PACS Group Slides: Q1 2026

May 12, 2026, 11:30 AM EDT - 6 weeks ago

PACS Group Slides: Q1 2026


Pacs Group  reports Q1 EPS 50c, consensus 41c

2026-05-11T23:51:37.000Z - 6 weeks ago

Pacs Group reports Q1 EPS 50c, consensus 41c


PACS Group, Inc. Reports First Quarter 2026 Results

May 11, 2026, 4:30 PM EDT - 6 weeks ago

PACS Group, Inc. Reports First Quarter 2026 Results


PACS Group Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

PACS Group Proxy statement: Proxy filing


PACS Group Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

PACS Group Proxy statement: Proxy filing


Pacs Group co-founder, CFO Mark Hancock to retire

2026-04-27T20:42:55.000Z - 2 months ago

Pacs Group co-founder, CFO Mark Hancock to retire


Pacs Group names Carey Hendrickson CFO

2026-04-27T20:42:37.000Z - 2 months ago

Pacs Group names Carey Hendrickson CFO


Pacs Group price target raised to $42 from $40 at Oppenheimer

2026-03-04T12:53:06.000Z - 4 months ago

Pacs Group price target raised to $42 from $40 at Oppenheimer


Pacs Group price target raised to $44 from $42 at UBS

2026-03-04T12:45:08.000Z - 4 months ago

Pacs Group price target raised to $44 from $42 at UBS


Pacs Group price target raised to $52 from $47 at RBC Capital

2026-02-27T14:57:17.000Z - 4 months ago

Pacs Group price target raised to $52 from $47 at RBC Capital


PACS Group Earnings Call Transcript: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Earnings Call Transcript: Q4 2025


PACS Group Annual report: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Annual report: Q4 2025


PACS Group Earnings release: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Earnings release: Q4 2025


PACS Group Slides: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Slides: Q4 2025


Pacs Group reports Q4 adjusted EBITDA $142.1M

2026-02-26T22:03:19.000Z - 4 months ago

Pacs Group reports Q4 adjusted EBITDA $142.1M


PACS Group Inc call buyer realizes 7% same-day gains

2026-02-18T13:00:20.000Z - 4 months ago

PACS Group Inc call buyer realizes 7% same-day gains


Pacs Group price target lowered to $40 from $48 at Truist

2026-01-05T12:26:30.000Z - 6 months ago

Pacs Group price target lowered to $40 from $48 at Truist


Pacs Group resumed with a Buy at UBS

2025-12-18T12:16:49.000Z - 6 months ago

Pacs Group resumed with a Buy at UBS


PACS Group Announces Business Updates

Dec 1, 2025, 4:15 PM EST - 7 months ago

PACS Group Announces Business Updates


PACS Group Proxy statement: Proxy Filing

Nov 25, 2025, 7:00 AM EST - 7 months ago

PACS Group Proxy statement: Proxy Filing


PACS Group Earnings Call Transcript: Q3 2025

Nov 19, 2025, 5:30 PM EST - 7 months ago

PACS Group Earnings Call Transcript: Q3 2025


PACS Group Earnings release: Q3 2025

Nov 19, 2025, 5:30 PM EST - 7 months ago

PACS Group Earnings release: Q3 2025


PACS Group Quarterly report: Q3 2025

Nov 19, 2025, 5:30 PM EST - 7 months ago

PACS Group Quarterly report: Q3 2025


PACS Group Slides: Q3 2025

Nov 19, 2025, 5:30 PM EST - 7 months ago

PACS Group Slides: Q3 2025


PACS Group, Inc. Reports Third Quarter 2025 Results

Nov 19, 2025, 4:30 PM EST - 7 months ago

PACS Group, Inc. Reports Third Quarter 2025 Results


PACS Group Annual report: Q4 2024

Mar 28, 2025, 8:00 AM EDT - 1 year ago

PACS Group Annual report: Q4 2024


ReigningTrades
ReigningTrades Jun. 25 at 3:31 AM
$PACS important few weeks coming up to see if we get some upside follow through. Would not mind an initial rejection in the 41-42 range but would like to see buyers absorbing and sellers defense weakening. Should be a picture-perfect cup & handle breakout by the time the leaves start falling!
0 · Reply
Doozio
Doozio Jun. 24 at 3:25 PM
$PACS $WEN ? ONTO 🐒🍌🧠⏰♾️
0 · Reply
DrabCrab5
DrabCrab5 Jun. 24 at 2:05 PM
$PACS Two solid updates: - JPM updated their model on 6/15 and increased their price target to $47 ($44 previously) - Ohio approved $875M in retroactive quality incentive payments for skilled nursing homes following a determination that they underpaid previous quality incentive payments. As of Q1, PACS operates nearly 8% of the states total SNF beds which means they should receive a nice make whole payment.
0 · Reply
Smokesdrugs
Smokesdrugs Jun. 22 at 7:52 PM
$PACS just needs to move like this more often and it’ll be in the $50+ range where it should be in no time.
0 · Reply
Doozio
Doozio Jun. 19 at 3:04 PM
$PACS chop chop huckleberries as rotation out of semis n AI stonks (which start to consolidate) find da proper bases on the DLO ONTO 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Jun. 19 at 2:48 PM
$PACS out of the tightness da 🧠 shall spread like its staying at da $ABNB ONTO 🐒🍌🧠⏰♾️
1 · Reply
DrabCrab5
DrabCrab5 Jun. 18 at 2:57 PM
$PACS another wrinkle to this name. Mark Hancock, one of the company’s co-founders, now has a 10b5-1 plan established to sell shares. This should not come as a huge surprise given his re-retirement after filling in as stop gap CFO, as well as his massive position (~54.5m shares owned). A reduction in his ownership and increased trading liquidity should be a good thing long term, but hard to say what kind of overhang (if any) this will be. I obviously have no idea what his planning situation looks like, how many shares he wants to hold on to, etc. but without a large secondary offering, it will take him multiple years to exit his full position given the average trading volume for PACS.
1 · Reply
DrabCrab5
DrabCrab5 Jun. 18 at 2:47 PM
$PACS with only 4 SNF acquisitions completed year to date, PACS is now lagging its target of ~20 per year. Given what they have communicated about the health of their M&A pipeline, I do wonder if they are working on a chunky deal. The balance sheet is clean (net leverage is below 0.5x), they have nearly $800M in available liquidity, and will continue to generate cash as we progress through the year. One would also imagine the government investigation will come to a close at some point. The government inquiry was technically opened back in November of 2024, and PACS gave the government the findings from its own internal investigation back in November of 2025.
1 · Reply
Smokesdrugs
Smokesdrugs Jun. 17 at 7:35 PM
$PACS these stocks are dead money right now. Why invest in this when AI/tech/tech adjacent are going parabolic? Anyone who owns this is simply early, huge portion of the population are going to be in their 60s and older in the next 4 years. The government investigation overhang and the sentiment that this industry is rife with fraud certainly doesn’t help either.
1 · Reply
Smokesdrugs
Smokesdrugs Jun. 15 at 3:47 PM
0 · Reply
Smokesdrugs
Smokesdrugs Jun. 10 at 7:01 PM
$PACS buybacks soon?
0 · Reply
ReigningTrades
ReigningTrades Jun. 10 at 2:17 AM
Check out this weekly & daily alignment on $PACS. Setting up perfectly — same way their business is positioned in the market. Love the value-add & acquisition-driven model. Been in since $8 and I believe we hit $50 on the next breakout, which the charts suggest is incoming. Two zones I'm watching: 🟢 Green (demand): If we tap in — especially if we break below and see legitimate demand come through — I'm adding to my position. 🔴 Red (supply): If we reject, I'll sell CCs short-term until next earnings. Once I see bullish alignment between volume, price, and liquidity at that supply zone (vs. previous rejections), I'll enter the core of my position and initiate mid/long-term spreads and LEAPs. Also if any of this $ENSG rumor becomes fact, a lot of new money could start flowing into this more exciting (and ethical) company.
1 · Reply
Smokesdrugs
Smokesdrugs Jun. 9 at 4:22 PM
$PACS the market hates this stock.
0 · Reply
ReigningTrades
ReigningTrades Jun. 9 at 9:36 AM
$PACS final shakeout on this pullback before $40
1 · Reply
Smokesdrugs
Smokesdrugs Jun. 8 at 3:16 PM
$PACS major indices green. VIX down. $PACS and $ENSG RED. Classic. I really don’t get it.
1 · Reply
Doozio
Doozio Jun. 5 at 12:07 AM
$PACS man is chop chop choping da huckleberries under da $$ ONTO 🐒🍌🧠⏰♾️
1 · Reply
Doozio
Doozio Jun. 2 at 4:37 PM
$PACS wen da huckleberries go thru da $$$ pattern ONTO 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Jun. 2 at 4:07 PM
$PACS even moar of a 🎁 va da gap. MAMA said it comes in 3s and this is da 2nd ONTA 🐒🍌🧠⏰♾️
1 · Reply
peloswing
peloswing Jun. 2 at 12:22 AM
$PACS has been triangulating and is nearing some support here at the 50 DMA. Could also go for the full earnings gap fill at $33.54. Puts got dumped today 🟢 - PACS Group Price Target Raised to $52.00/Share From $50.00 by Truist Securities, Maintained at Buy 🐂
0 · Reply
Smokesdrugs
Smokesdrugs May. 29 at 4:08 PM
$PACS I guess the market isn’t particularly interested in this sector right now. Huge gains to be made over in tech, semis, and space stocks.
0 · Reply
TheBullishTrade
TheBullishTrade May. 26 at 1:22 PM
$ODD $SMCI $PACS ODD: Currently trading like Business worth zero. In my trading career, some of the biggest opportunities have arisen when fundamentally strong companies encounter short-term, temporary challenges that trigger an outsized decline in their stock price. I’ve witnessed this pattern firsthand with names like PACS and SMCI, both of which experienced sharp pullbacks before delivering strong recoveries once the issues resolved. I believe ODD presents a similar attractive risk-reward setup today. 2025: 810 million revenue up 25% Gross margin: 72% Cash: 776 million plus 300 million credit line Market cap: 700 million Platform users: 68 million A company whose cash reserves exceed its market capitalization, featuring an advanced AI personalization engine not yet reflected in its valuation, and a proven brand-building operation hidden within a stock that was severely undervalued due to misguided concerns. Let me repeat: This is only for High risk tolerant investors. Do your research. This is not a financial advice.
2 · Reply
Smokesdrugs
Smokesdrugs May. 22 at 8:07 PM
$PACS I mostly buy and hold stocks and don’t really look at them on a daily basis. This one is an exception due to the debacle and ongoing government investigation. So, can someone who is more into stocks and technical analysis explain why that anytime $PACS makes gains, said gains are sold off immediately. Very often with in the same day. Like today’s behavior. No other stock in my portfolio behaves this way. Why?
0 · Reply